Related Experiment Video
Updated: Jan 19, 2026

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
Published on: June 2, 2018
Management of Exocrine Pancreatic Insufficiency in Children
Senthilkumar Sankararaman1, Teresa Schindler2, Thomas J Sferra1
1Division of Pediatric Gastroenterology, Department of Pediatrics, UH Rainbow Babies & Children's Hospital, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Insights
Diagnosing exocrine pancreatic insufficiency (EPI) in children is challenging. Early diagnosis and treatment with pancreatic enzyme replacement therapy and nutritional support are crucial for growth and preventing malabsorption.
Area of Science:
- Pediatric Gastroenterology
- Nutritional Science
- Endocrinology
Background:
- Exocrine pancreatic insufficiency (EPI) diagnosis can be difficult due to nonspecific symptoms.
- Delayed diagnosis negatively impacts children's health, causing poor weight gain, impaired growth, and malabsorption.
- Children are particularly vulnerable to untreated EPI consequences due to active growth and development.
Purpose of the Study:
- To highlight the diagnostic challenges of EPI in children.
- To emphasize the importance of timely diagnosis and management.
- To review current therapeutic strategies for pediatric EPI.
Main Methods:
- Literature review focusing on pediatric exocrine pancreatic insufficiency.
- Analysis of diagnostic criteria and clinical presentation.
- Evaluation of treatment outcomes for pancreatic enzyme replacement therapy and nutritional support.
Main Results:
- Pancreatic enzyme replacement therapy is essential for symptomatic relief and improved clinical outcomes.
- A high-energy diet, unrestricted fat intake, and fat-soluble vitamin supplementation are vital for optimal growth.
- Cystic fibrosis is the leading cause of pediatric EPI, with nutritional improvements linked to better pulmonary function and survival.
Conclusions:
- Effective management of pediatric EPI requires prompt diagnosis and comprehensive treatment.
- Nutritional support and pancreatic enzyme replacement therapy are cornerstones of care.
- Further research is needed for managing non-CF causes of EPI in children.
Abstract:
The diagnosis of exocrine pancreatic insufficiency (EPI) can be difficult, as symptoms may be nonspecific. A delayed diagnosis of EPI can negatively impact health through poor weight gain, impaired growth, and malabsorption of nutrients. Because of active growth and development, children are more vulnerable to the consequences of untreated EPI. Pancreatic enzyme replacement therapy is the cornerstone of management and offers both symptomatic relief and improvement in clinical outcomes. Additionally, a high-energy diet with unrestricted fat and supplementation with fat-soluble vitamins is often required to optimize growth and prevent nutrition deficiencies. Cystic fibrosis (CF) is the most common condition in children that causes EPI, and improvement in nutrition management is associated with improved pulmonary function and increased survival. Currently, the management of other conditions leading to EPI in children is not well studied, and inferences from the CF literature are often necessary in caring for these patients.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Insulin Secretory Vesicles
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

